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Exposure of the pulmonary pathogen Aspergillus fumigatus to amphotericin B alters membrane
permeability as indicated by the escape of amino acids and protein from themycelium. Amphotericin
B exposure for periods of 2–4 h also leads to increased release of the immunosuppressive agent
gliotoxin into the surrounding culturemedium. Examination of the intracellular gliotoxin concentration
following exposure to amphotericin B indicated elevated levels within the hyphae as well as in the
culture medium – an effect which was also evident upon exposure ofA. fumigatus to DMSO. These
results indicate that in parallel with the ability of amphotericinB to act as a fungistatic agent it can also
induce the synthesis of gliotoxin and facilitate its release by increasing the permeability of the fungal
cell membrane. Increased synthesis of gliotoxin may result from the commencement of secondary
metabolism in the presence of amphotericin B. The ability of amphotericin B to enhance the
synthesis and release of gliotoxinmay exacerbate the effects of the toxin and facilitate fungal invasion
of pulmonary tissue.
INTRODUCTION
The fungus Aspergillus fumigatus is a pulmonary pathogen
capable of inducing disease in those with pre-existing
pulmonary malfunction (e.g. asthma, cystic fibrosis), disease
(e.g. tuberculosis, lung cancer) or undergoing immuno-
suppressive therapy prior to organ transplantation
(Denning, 1996a; Fraser, 1993; Daly & Kavanagh, 2001).
Three forms of aspergillosis are recognized clinically: sapro-
phytic, allergic and invasive. Invasive aspergillosis (IA) is the
most serious form of disease as it involves the invasion of
viable tissue and may produce a mortality rate of 80–95%
(Denning, 1996b, 1998). IA has emerged as an important
disease in recent decades due to the use of aggressive
immunosuppressive therapy causing prolonged neutropenia
in the treatment of cancer and leukaemia (Daly & Kavanagh,
2001). Despite aggressive anti-fungal chemotherapy, death
due to IA usually results 7–14 days post-diagnosis (Denning,
1996b).
A. fumigatus produces a range of secondary metabolites such
as gliotoxin, helvolic acid and fumagillin whichmay facilitate
its growth and persistence in the lung (Amitani et al., 1995a;
Hogan et al., 1996). Extracts obtained from sputum sols of
patients with aspergillosis damage human respiratory epithe-
lial cells (Amitani et al., 1995a). Subsequent analysis con-
firmed that gliotoxin derived fromA. fumigatuswas the toxic
agent and that helvolic acid was also capable of complete
ciliostasis and epithelial cell disruption (Amitani et al.,
1995b).
Gliotoxin (C13H14N2O4S2, molecular mass 326.4) is an
epipolythiodioxopiperazine (Waring & Beaver, 1996) which
displays immunosuppressive properties in vivo (Sutton et al.,
1994). Gliotoxin is capable of inhibiting macrophage func-
tion and adherence to plastic surfaces (Bertout et al., 2002;
Eichner et al., 1986) and may alter the immune response to
Aspergillus as it can induce apoptotic cell death in macro-
phages (Waring, 1990), cells of the spleen (Braithwaite et al.,
1987) and the immune system (Sutton et al., 1994). The
immunosuppressive properties of gliotoxin have been eval-
uated for suppressing the whole body immune response
prior to organ transplantation (Sutton et al., 1995). Gliotoxin
is also capable of inducing cell death in a murine fibroblastic
cell line (Piva, 1994). Gliotoxin has been detected in samples
from animals (Richard & DeBey, 1995; Richard et al., 1996)
and humans (Shah et al., 1995) where it may facilitate fungal
persistence and colonization of tissue. In addition, gliotoxin
has been implicated in the destruction of lung parenchyma in
IA (Sutton et al., 1996) and the penetration of blood vessels in
angio-invasive aspergillosis (Fraser, 1993)
Conventional therapy for the control of aspergillosis relies
upon the use of the polyene, amphotericin B (Ellis, 2002) and
the azoles, itraconazole and fluconazole (Canuto & Rodero,
2002). Amphotericin B displays fungistatic activity and
functions by forming apertures in the cell membrane, by
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complexing the membrane sterol, ergosterol (Abu-Salah,
1996). Each pore consists of an annulus of eight ampho-
tericin Bmolecules linked hydrophobically to ergosterol. The
hydroxyl residues of the polyene drug face inwards to give an
effective pore diameter of 0.4–1.0 nm. Amphotericin B–
ergosterol pores allow the exit of intracellular constituents
(e.g. ions and small molecular mass compounds) and the
entry of hydrogen ions leading to increased cytoplasmic
acidity (Cohen, 1998). While amphotericin B can induce the
formation of apertures in the fungal cellmembrane, the effect
may not be fatal to the cell and ‘recovery’ may be possible
(Liao et al., 1999). It has been established that while a specific
concentration of amphotericin B may inhibit replication, as
indicated by lack of fungal growth, specific cellular functions
(e.g. trans-membrane potential, intracellular enzyme activity
and membrane integrity) still operate and, over time, the
fungusmay resume the ability to grow and divide (Liao et al.,
1999).
An alternative explanation for the mode of action of ampho-
tericin B has recently been proposed and suggests that, in
addition to the formation of pores in the fungal cell
membrane, amphotericin B also alters the permeability of
the phospholipid bilayer by changing the membrane phase,
i.e. increasing the fluidity of the bilayer (Venegas et al. 2003).
However, the dominant effect of amphotericin B appears to
be the formation of pores in the membrane by complexing
ergosterol.
The ability of amphotericin B to induce the release of
intracellular constituents in Candida albicans via membrane
apertures has been established previously (Ghosh & Ghosh,
1963) and raises the possibility of the release of lowmolecular
mass toxins frompathogenic fungi. Consequently, the aim of
this study was to establish whether exposure of A. fumigatus
to amphotericin B could lead to the release of a lowmolecular
mass toxin such as gliotoxin; a process which could have the
potential to exacerbate the immunosuppressive and invasive
abilities of A. fumigatus.
MATERIAL AND METHODS
A. fumigatus culture conditions. A. fumigatus ATCC 26933 (ob-
tained from the American Type Culture Collection) was used in this
study. Aspergillus cultures were grown in minimal essential medium
Eagle (MEM) (Sigma Aldrich) or RPMI medium supplemented with
5% (v/v) fetal calf serum (SigmaAldrich) at 37 8C and 200 r.p.m., for up
to 4 days. Stocks were maintained on malt extract agar (MEA) (Oxoid).
Effect of amphotericin B on growth of A. fumigatus. MEA plates
containing sporulating Aspergillus colonies were washed with 10 ml
0.1% (v/v) Tween 80 (Merck) in PBS (pH 7.2) (Sigma Aldrich) to
isolate conidia. Conidia were washed twice in sterile PBS, centrifuged
(1500 g, 5 min in a Beckman GS-6 centrifuge) and counted using an
haemocytometer. Flasks containingMEM (25ml) were inoculated with
1 3 105 Aspergillus conidia to give a density of 4 3 103 ml1 and
incubated at 37 8C and 200 r.p.m. Cultures were supplemented with
amphotericin B at final concentrations of 0.04, 0.08, 0.16 and
0.32 gml1. Flasks were removed at each time point and the contents
filtered through a Whatman No. 1 filter in a Bu¨chner funnel and air-
dried. A growth curve was constructed of dry fungal biomass versus
incubation time.
Evaluation of membrane leakage. Seventy-two-hour-old cultures
(25 ml) of A. fumigatus were harvested by centrifugation (2056 g, 20
min), washed three times in PBS and the hyphal mass resuspended in
25 ml PBS. Amphotericin B (0.04, 0.08, 0.16 or 0.32 gml1) or DMSO
(Sigma Aldrich) (0.5% v/v) was added and the cultures incubated at
37 8Cand 200 r.p.m. for a further 1, 2 or 4 h. At each time point a culture
was removed and the contents filtered through aWhatman No. 1 filter.
The filtrate was passed through a 0.45 M syringe filter (Sartorius) and
free amino acids or protein were measured as described below.
Amino acid concentration was determined by the ninhydrin colori-
metric method and is expressed in terms of aspartic acid and glutamic
acid, which were used as standards. A ninhydrin (Sigma Aldrich)
solution (200 l; stock: 0.35 g in 100 ml ethanol) was added to each
sample (1 ml) and heated to 95 8C for 4 min. After cooling to room
temperature in an ice bath, the absorbance at 570 nmwas recorded on a
spectrophotometer (Beckman DU 640).
To determine the quantity of protein released from the hyphal mass,
samples were assayed using the Bradford reagent (Bio-Rad), with BSA
(Sigma Aldrich) as standard.
Extraction of gliotoxin from A. fumigatus culture filtrate. Hyphae
of Aspergillus were removed from the MEM culture medium or RPMI
medium by filtration and an equal volume (25 ml) of chloroform
(Hyper Solv; BDH) was added to the filtrates. Following continual
mixing for 30 min, the chloroform fraction was collected and evapo-
rated to dryness in a Bu¨chi (Brinkmann Instruments; Westbury, NY)
rotor evaporator. Dried extracts were dissolved in 250 l methanol
(Hyper Solv, BDH) and stored at 70 8C until assayed.
Extractionofgliotoxin fromhyphaeofA. fumigatus.The extraction
of intracellular gliotoxin from hyphae of A. fumigatus was performed as
follows: hyphae were recovered fromMEM culture medium (50 ml) or
RPMI medium (50 ml) by filtration. Hyphae were washed in PBS and
ground to a fine powder under liquid N2 using a pre-chilled pestle and
mortar. The ground hyphae were resuspended in 10 ml 6 M HCl.
Chloroform (50 ml) was added and the mixture stirred at room
temperature for 30 min. The sample was poured into a separation
funnel and the gliotoxin extracted in the lower chloroform layer.
Following chloroform evaporation, the dried extracts were dissolved
in 250 l methanol and levels of gliotoxin quantified by Reversed Phase-
HPLC.
Quantification of gliotoxin by HPLC. Gliotoxin was detected by
Reversed Phase-HPLC (Spectra-Physics). The mobile phase was 34.9%
(v/v) acetonitrile (Hyper Solv, BDH), 0.1% (v/v) trifluoroacetic acid
(Sigma Aldrich) and 65% (v/v) deionized-distilled water. Gliotoxin
extract (20 l) was injected onto a C18 Hewlett Packard column. A
standard curve of peak area versus gliotoxin concentration was
constructed using gliotoxin standards (50, 100 and 200 ngml1)
dissolved in methanol (Sigma Aldrich).
Statistical analysis. All assays were performed on three independent
occasions. Results presented are the mean  standard error. Statistical
analysis were performed using Student’s two tailed t-test with values of
P , 0.05 considered statistically significant.
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RESULTS
The effect of amphotericin B on the growth of A.
fumigatus
Culturemediumwas inoculated with conidia ofA. fumigatus
at an initial density of 4 3 103 ml1 and incubated as
described. An untreated culture and four cultures supple-
mented with different concentrations of amphotericin B
were used. The results (Fig. 1) indicate that while the
concentrations of amphotericin B employed here act as
fungistatic agents over the first 24 h, the rate of growth of
the cultures supplemented with 0.04 and 0.08 g ampho-
tericin B ml1 is approximately the same as the control over
the 24–72 h period. Following 96 h incubation, the treated
cultures reached a mass of approximately 65–70% of that of
the control. This experiment demonstrated that the concen-
trations of amphotericin B chosen for subsequent work were
fungistatic rather than fungicidal, as used clinically (Liao et
al., 1999).
To verify that the amphotericin B concentrations employed
in subsequent experiments were fungistatic rather than
fungicidal, 48 h cultures of A. fumigatus [hyphal mass
127.9 mg (dry weight)] grown in MEM culture medium
were supplemented with amphotericin B at final concentra-
tions of 0.16 or 0.32 gml1 and grown for a further 24 h.
Hyphae were harvested, washed with PBS and resuspended
in fresh medium for 24 h in the absence of amphotericin B.
The hyphal mass of the culture supplemented with 0.16 g
amphotericin B ml1 had increased to 155.4 mg (dry weight)
while that of the culture supplemented with amphotericin B
at a concentration of 0.32 gml1 was 111.6 mg (dry
weight). This finding indicates that amphotericin B at
0.16 gml1 does not prevent subsequent growth of the
culture, and that the 0.32 gml1 amphotericin B treatment
does not cause wide-scale hyphal cell death, as the dry weight
was still 87% of the untreated control.
The effect of amphotericin B on release of
intracellular constituents from A. fumigatus
It has been established previously that amphotericin B can
induce the release of intracellular constituents from patho-
genic fungi (Ghosh&Ghosh, 1963; Cohen, 1998).We sought
to establish whether this occurred in A. fumigatus and to
determine whether it contributed to the enhanced release of
low molecular mass compounds. Seventy-two-hour-old
cultures of A. fumigatus were exposed to amphotericin B at
final concentrations of 0.04, 0.08, 0.16 or 0.32 gml1 or
0.5% (v/v) DMSO for 1, 2 or 4 h and the release of amino
acids and protein was monitored. DMSOwas employed here
as a positive control since it is known to alter the permeability
of the cell membrane (Yu & Quinn, 1998). The results show
that exposure to 0.16 or 0.32 g amphotericin B ml1 or
0.5% DMSO for periods of 2 or 4 h lead to the release of
elevated levels of amino acids compared to the relevant
controls (Fig. 2). In the case of exposure of A. fumigatus to
0.32 g amphotericin B ml1 for 4 h, 2.741  0.069 g
amino acid (mg hyphae)1 was released.
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Fig. 1. Effect of amphotericin B on the growth of A. fumigatus. Culture
medium was supplemented with amphotericin B prior to inoculation
with A. fumigatus conidia. d, Control; s, 0.4; j, 0.08; h, 0.16; n,
0.32 g amphotericin B ml1. The hyphal mass was determined at
24 h intervals.
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Fig. 2. Effect of amphotericin B on release of amino acids from
hyphae of A. fumigatus. Cultures of A. fumigatus were supplemented
with amphotericin B and the release of amino acids was assessed
using the ninhydrin assay. DMSO was used as a positive control at a
concentration of 0.5 % (v/v). *, Statistically significant (P , 0.05)
difference compared to the relevant control.
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Enhanced protein release from A. fumigatus was also evident
after exposure to amphotericin B for 2 or 4 h (Fig. 3). In this
case the greatest release occurred when 0.32 g amphotericin
B ml1 was employed for 4 h (35.57  2.56).
Release of gliotoxin from A. fumigatus exposed to
amphotericin B
Amphotericin B can induce the release of amino acids and
protein from cultures of A. fumigatus over a relatively short
time period (Figs 2 and 3). Since gliotoxin is a lowmolecular
mass dipeptide it could escape from A. fumigatus in the same
manner as amino acids andproteins. Cultures ofA. fumigatus
which had been grown for a period of 72 h to a hyphalmass of
29 mg were supplemented with amphotericin B at final
concentrations of 0.04, 0.08, 0.16 or 0.32 gml1 and the
amount of gliotoxin in the culture filtrates was assessed at
various time points after the addition. After 1 h, the control
culture demonstrated a gliotoxin concentration of
210.3  36.1 ng (mg hyphae)1 (Fig. 4). Those cultures
supplemented with 0.16 or 0.32 g amphotericin B ml1
showed elevated levels of gliotoxin in the culture super-
natants, particularly after 2 and 4 h. The highest concentra-
tion of gliotoxin [506.6  24.7 ng (mg hyphae)1] was
detected in the culture supplemented with 0.32 g ampho-
tericin B ml1 after 2 h incubation (Fig. 4).
EffectofDMSOongliotoxin releasebyA. fumigatus
Amphotericin B functions by binding ergosterol in the fungal
cell membrane and creating pores through which intracellu-
lar constituents may escape (Abu-Salah, 1996). It was
postulated that the elevated levels of gliotoxin observed in
amphotericin-B-supplemented cultures could be due to the
increased permeability of the fungal cell membrane. To test
this hypothesis 72-h-old cultures of A. fumigatus were
supplemented with DMSO, which also has the ability to alter
the permeability of cellmembranes, but in a differentmanner
to amphotericin B (Yu & Quinn, 1998). The results demon-
strated a significant increase in gliotoxin in the culture
medium after 2 h in those cultures supplemented with
0.5% DMSO (Fig. 5). Following 4 h exposure to DMSO,
the gliotoxin concentration in the culture medium supple-
mented with 0.5% DMSO reached a value of
431.14  23.1 ng (mg hyphae)1.
Examination of intracellular and extracellular
concentration of gliotoxin following exposure of
A. fumigatus to amphotericin B or DMSO
The elevated levels of gliotoxin in amphotericin-B- or
DMSO-supplemented cultures may be due to increased
membrane permeability. Alternatively, the two agents could
exert a fungistatic effect and this might, in turn, lead to the
increased synthesis of secondary metabolites such as gliotox-
in. To ascertain whether this was the case the gliotoxin
concentration in supplemented medium and in the hyphae
of A. fumigatus was determined. In this case cultures were
grown for 48 h and then supplemented with the relevant
concentration of amphotericin B or DMSO for a further
24 h. The results revealed enhanced levels of gliotoxin in the
hyphae as well as in the culture medium of those cultures
supplemented with amphotericin B or DMSO (Fig. 6).
The intra-hyphal gliotoxin concentration in the culture
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Fig. 3. Protein release from A. fumigatus following exposure to
amphotericin B. Cultures were supplemented with amphotericin B
and the release of protein from hyphae was measured. DMSO was
used as a positive control at a concentration of 0.5 % (v/v). *,
Statistically significant (P , 0.05) difference compared to the rele-
vant control.
Amphotericin B (µg ml–1)
G
lio
to
xi
n 
[n
g 
(m
g 
hy
ph
ae
)–
1
]
1 h
2 h
4 h
0
100
200
300
400
500
600
Co
n
0·
04
0·
08
0·
16
0·
32 Co
n
0·
04
0·
08
0·
16
0·
32 Co
n
0·
04
0·
08
0·
16
0·
32
*
*
*
*
* * *
Fig. 4. Release of gliotoxin from A. fumigatus cultures supplemented
with amphotericin B. The concentration of gliotoxin in amphotericin-B-
supplemented cultures was assessed by HPLC analysis. *, Statistically
significant (P , 0.05) difference compared to the relevant control.
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supplemented with 0.16 g amphotericin B ml1 was 732.1
 37.9 ngmg1 compared to the control which showed a
gliotoxin concentration of 88.6  4.9 ngmg1. Similarly, the
gliotoxin concentration in the MEM culture medium was
273.5  11.9 ngml1 compared to 146.1  4.5 ngml1 in
the control. In the case of the cultures supplemented with
0.5% (v/v)DMSO, the gliotoxin concentration in the culture
medium was 227  12.1 ngml1 (control: 146.1  14.5
ngml1) while that in the hyphae was found to be
405.5  20.2 ngmg1 compared to 88.6  4.9 ngmg1 in
the relevant control. In the case of A. fumigatus grown in
RPMImedium (Fig. 6) the extracellular gliotoxin concentra-
tion was 39.47  1.2 ngml1 in the control whereas it was
205.19  8.2 ngml1 when the culture was supplemented
with amphotericin B at a final concentration of 0.16 gml1.
The intracellular gliotoxin concentration increased from
3.63  0.13 ng (mg hyphae)1 in the control to 41.4 
0.74 ng (mg hyphae)1 in the amphotericin-B-treated cul-
ture. Although different levels of gliotoxin were produced by
A. fumigatus in MEM and RPMI culture media, the ability of
amphotericin B to increase the intracellular and extracellular
gliotoxin levels was observed in cultures grown in both
media.
DISCUSSION
Infection by A. fumigatus is a serious threat to the health of
patients immunocompromised as a result of disease, pul-
monary malfunction or medical therapy (Daly & Kavanagh,
2001) and, in the case of IA, may have a mortality rate of 85–
90% (Denning, 1996b). Part of the ability of A. fumigatus to
colonize the lung is its capacity to suppress the local immune
response (Hogan et al., 1996). This can be achieved through
the action of toxins and enzymes, and the ability of gliotoxin
to facilitate colonization is well characterized (Sutton et al.,
1995 & 1996). Gliotoxin may suppress the function of
pulmonary macrophages and also affect the general immune
response to pathogens by destroying cells of the spleen and
the immune system (Sutton et al., 1994).
One of the principal drugs used to combat aspergillosis is the
polyene amphotericin B, which creates pores in the fungal
cell membrane through which intracellular constituents
escape (Abu-Salah, 1996; Cohen, 1998). It was postulated
that such pores might also serve to allow gliotoxin to escape
from the hyphae of A. fumigatus, which could exacerbate
gliotoxin-mediated damage to pulmonary tissue and the
suppression of the immune response in the infected patient.
As a consequence we sought to determine the response of
hyphae of A. fumigatus to amphotericin B in terms of the
synthesis and release of gliotoxin.
Using fungistatic concentrations of amphotericin B (Fig. 1) it
was established that exposure of cultures of A. fumigatus to
amphotericin B increased the release of amino acids (Fig. 2)
and protein (Fig. 3) 2–4 h after addition. These finding
suggested that amphotericin B was inducing the release of
intracellular constituents from the fungal hyphae, possibly
through the creation of pores in the cell membrane. Elevated
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levels of gliotoxin were also detected in media of cultures
supplemented with amphotericin B (Fig. 4) or DMSO (Fig.
5). DMSO is commonly used as a solvent in biological science
and can alter cell permeability by affecting the structure and
interaction of lipids in membranes (Yu & Quinn, 1998;
Gordeliy et al., 1998) which may explain the release of amino
acids, protein and gliotoxin observed here.
Given the previously established ability of amphotericin B to
induce the release of intracellular constituents from C.
albicans (Ghosh & Ghosh, 1963), it appeared that this
mechanism might also be operating here to facilitate the
release of gliotoxin. However, when the intracellular con-
centration of gliotoxin was ascertained it was found to be
elevated, along with raised levels detected in the culture
supernatant. In the case ofMEMcultures supplemented with
0.08 or 0.16 g amphotericin B ml1, the intracellular
concentration of gliotoxin rose from 88.6  4.9 ngmg1 to
217.38  18.8 ngmg1 and 732.1  37.9 ngmg1, respec-
tively (Fig. 6). This effect was also apparent in RPMI-grown
cultures of A. fumigatus.
The increased concentration of gliotoxin in culture super-
natant may be explained by the well established ability of
amphotericin B to increase the permeability of the fungal cell
membrane via the creation of pores (Ghosh & Ghosh, 1963;
Cohen, 1998). However, the elevated level of intracellular
gliotoxin could also contribute to the higher levels detected
in the culture. The ability of amphotericin B to increase the
synthesis of gliotoxin may be mediated through its fungi-
static abilities. When applied to cultures of C. albicans,
amphotericin B halts replication but the cells remain viable
(Liao et al., 1999) and the fungus may recover the ability to
divide in the absence of the polyene. Halting the cell’s growth
may force the production of secondary metabolites such as
gliotoxin. In effect amphotericin B may have two distinct
effects on the fungal cell: (i) The fungistatic effect may halt
replication, leaving the cell alive but capable of synthesizing
secondarymetabolites such as gliotoxin; (ii) The ability of the
polyene to create apertures in the fungal cell membrane
allows the escape of small molecular mass compounds,
including gliotoxin. The consequence of amphotericin B
exposure at the cellular level would be elevated synthesis and
release, via membrane apertures, of gliotoxin.
Although DMSO has a different primary effect on cell
membranes (Yu & Quinn, 1998), it also induces elevated
synthesis and release of gliotoxin. In the case of exposure ofA.
fumigatus to DMSO, the elevated levels of gliotoxin in the
supernatant may be due to the increased permeability of the
fungal cellmembrane. The leakage ofmetabolitesmay hinder
the cell’s ability to divide, temporarily allowing it synthesize
secondary metabolites such as gliotoxin.
The work presented here indicates that when exposed to
amphotericin B in vitro A. fumigatus produces and secretes
the immunosuppressive agent gliotoxin at an elevated rate.
Amphotericin B therapy has many undesirable side effects
(Cohen, 1998) and new formulations are designed to
minimize the toxicity towards host tissue (Hartsel & Bolard,
1996). Apart from its direct effect on the host, amphotericin
B may also induce the synthesis and release of secondary
metabolites by A. fumigatus which may contribute to greater
pulmonary damage and decreased immune function both
locally and systemically. While the work presented here
examined the response of A. fumigatus to amphotericin B
in an in vitro model, in vivo evaluation of this phenomenon
may be required to fully assess its clinical significance. Recent
work has indicated that fungi can survive exposure to
relatively high levels of amphotericin B, maintain certain
cellular functions and potentially resume replication (Liao et
al., 1999). This study has established that amphotericin B
may induce the synthesis and release of gliotoxin from A.
fumigatus. This phenomenon has the potential to contribute
to elevated levels of pulmonary damage (Eichner et al., 1986;
Sutton et al., 1996) and immunosuppression (Sutton et al.,
1994, 1995) associated with this toxin.
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